| | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = $0 ) |
| | 2027 | 2025 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Cause and Prevention Research | 000 | 5 | 10/23/2026 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2026 ( Subtotal = $351,656 ) |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Cause and Prevention Research | 000 | 6 | 7/7/2026 | SUPPLEMENT FOR EXPANSION | $351,656 |
|
 | Issue Date FY: 2025 ( Subtotal = $435,253 ) |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Cause and Prevention Research | 002 | 5 | 7/1/2025 | NON-COMPETING CONTINUATION | $337,605 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Biology Research | 004 | 5 | 8/8/2025 | SUPPLEMENT FOR EXPANSION | $97,648 |
| | 2025 | 2024 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Cause and Prevention Research | 001 | 4 | 6/16/2025 | TERMINATION | $0 |
| | 2025 | 2024 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Cause and Prevention Research | 000 | 4 | 6/6/2025 | NON-COMPETING CONTINUATION | $0 |
| | 2025 | 2024 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Cause and Prevention Research | 003 | 4 | 7/11/2025 | OTHER REVISION | $0 |
|
 | Issue Date FY: 2024 ( Subtotal = $501,996 ) |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Cause and Prevention Research | 001 | 4 | 7/15/2024 | SUPPLEMENT FOR EXPANSION | $96,763 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Cause and Prevention Research | 002 | 4 | 7/18/2024 | SUPPLEMENT FOR EXPANSION | $79,219 |
| | 2024 | 2024 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Cause and Prevention Research | 000 | 4 | 6/28/2024 | NON-COMPETING CONTINUATION | $326,014 |
|
 | Issue Date FY: 2023 ( Subtotal = $423,195 ) |
| | 2023 | 2023 | UNIVERSITY OF CALIFORNIA, IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Cause and Prevention Research | 000 | 3 | 6/9/2023 | NON-COMPETING CONTINUATION | $341,474 |
| | 2023 | 2023 | UNIVERSITY OF CALIFORNIA, IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Cause and Prevention Research | 001 | 3 | 6/27/2023 | SUPPLEMENT FOR EXPANSION | $81,721 |
|
 | Issue Date FY: 2022 ( Subtotal = $454,718 ) |
| | 2022 | 2022 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Cause and Prevention Research | 000 | 2 | 6/28/2022 | NON-COMPETING CONTINUATION | $344,801 |
| | 2022 | 2022 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Cause and Prevention Research | 002 | 2 | 8/24/2022 | SUPPLEMENT FOR EXPANSION | $83,389 |
| | 2022 | 2022 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Cause and Prevention Research | 001 | 2 | 7/6/2022 | NON-COMPETING CONTINUATION | $26,528 |
|
 | Issue Date FY: 2021 ( Subtotal = $361,260 ) |
| | 2021 | 2021 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Cause and Prevention Research | 000 | 1 | 2/9/2021 | NEW | $361,260 |
|
|